| A-N |
Description |
|
O-X |
Description |
| AUC |
Area
under the curve |
|
Oral |
Oral bioavailability
(adult) |
BID
|
Twice
daily |
|
PB |
Percent
of protein binding in maternal circulation |
Cmax
|
Plasma
or mild concentration at peak |
|
PHL |
Pediatric
elimination half-life |
| MAOI |
Monoamine
oxidase inhibitors |
|
pKa |
The
PH at which the drug is equally ionic and nonionic |
| Ci |
Microcurie
of Radioactivity |
|
PRN |
As
needed |
| g/L |
Microgram
per liter |
|
q |
Every |
mol
|
Micromole
of weight |
|
QD |
Daily |
| mg/L |
Milligram per
liter |
|
QID |
Four
Times Daily |
| ml |
Milliliter.
One cc |
|
RID |
Relative
Infant Dose |
| mmol |
Millimole
of weight |
|
T1/2 |
Adult
elimination half-life |
| M/P |
Milk/Plasma
Ratio |
|
TID |
Three
times daily |
| MW |
Molecular
Weight |
|
Tmax |
Time
to peak plasma level (PK) |
| ng/L |
Nanogram
per liter |
|
VD |
Volume
of Distribution |
| NSAIDs |
Non-steroidal
anti-inflammatory |
|
X |
Times |
